PAM²L Biotechnologies
柏垠生物（深圳柏垠生物科技有限公司）
The most Coolvex-specific biomaterial lead in the shortlist — a Shenzhen synthetic-biology company whose star molecule is a recombinant mussel adhesive protein with skin-repair, anti-inflammatory and wet-adhesion properties.
- Location
- Shenzhen synthetic-biology cluster (SIAT-origin; district not verified) · Shenzhen
- Visit window
- From the Nanshan base · Jul 13–31
- Source status
- medium confidenceresearched
Next action
Prepare the private outreach route and meeting ask; keep contact details out of the app.
Why now: Visit window · From the Nanshan base · Jul 13–31
What they do
Founded in 2021, PAM²L develops biomaterials driven by both synthetic biology and machine learning (BT-IT), engineering microorganisms as factories to produce protein and polysaccharide raw materials for pharmaceuticals, medical aesthetics, cosmetics and food. Its flagship is a recombinant mussel adhesive protein — bio-derived, with repairing and anti-inflammatory benefits and wet-adhesion.
Public exhibitor listings also reference a recombinant Type V mussel adhesive protein and a product named 'Colamin' (not independently confirmed on the live, JS-rendered site).
Why it matters
Medium-high fit. Primary relevance is platform-adjacent: an engineered-microbe / ML-guided strain-design house that demonstrates microbial-resource-to-biomaterial translation — a useful synbio peer and co-development reference for Pure Advance's discovery-plus-biomanufacturing-plus-AI core.
Secondary topical fit is genuine and strong: the recombinant mussel-adhesive protein (wet-adhesion, skin-repair, anti-inflammatory) could support delivery/retention and barrier repair for the Coolvex sensitive-area line at a high level. Caveat: it is a materials/co-development partner, not obviously an external fermentation CDMO.
Visit objective & route
Benchmark ML-driven strain/protein design and microbial production against Pure Advance's discovery pipeline, and scope the recombinant mussel-adhesive protein as a possible Coolvex ingredient or co-development lead.
Approach route
Appointment-only; approach directly via the company after confirming details, or via the Shenzhen synbio / SIAT ecosystem.
Talking points
- Is the recombinant mussel-adhesive protein available as a cosmetic raw-material sample?
- INCI / NMPA status, and an international regulatory pack?
- Safety, irritation and sensitization data, and stability in an ointment base?
- Could you support a small pilot formulation collaboration for sensitive-area topical use?
- Bring: a Pure Advance one-pager, a delivery/retention requirements brief, and an NDA template.
Open questions
- Exact district/area and nearest metro — not verified (public site is JS-rendered with no plain-text address).
- Whether the recombinant mussel adhesive protein is available as a cosmetic/raw-material sample; INCI/NMPA status; international regulatory pack.
- Safety/irritation/sensitisation data and protein stability in an ointment base with preservatives.
- 'Colamin' / Type V mussel protein details (listing-only, unconfirmed).
- Whether they can support a small pilot formulation collaboration, and on what IP terms.
- Confirm the correct business/BD contact and current funding round (public listing values unverified).
Risks & unknowns
- A materials/co-development partner, not obviously an external fermentation CDMO — treat as a parallel biomaterial lead, not the manufacturing solution.
- Medium confidence: exact address, contact and current funding/capacity are unverified.
- Public site is JS-rendered with no extractable address — confirm the district before any visit.
- Appointment-only.
Private-pack boundary